Jan 27th, 2023
Late-Breaking Science to be presented today
Seven trial presentations close out this week of Late-Breaking Science.
11 a.m.- 1:05 p.m., Friday, Feb. 10
- Blood Pressure After Endovascular Stroke Treatment (BEST)-II: A Randomized Clinical
- Early Antihypertensive Treatment With Delayed Antihypertensive Treatment for Acute Ischemic Stroke (CATIS-2): A Multicenter Randomized, Open-Label, Blinded-Endpoint, Phase 3 Trial
- A Randomized Trial of Endovascular Therapy for Acute Ischemic Stroke With a Large Infarct Core
- A Randomized Trial of Endovascular Thrombectomy Versus Medical Management for Ischemic Stroke With a Large Ischemic Core on Non-Contrast CT or Perfusion Imaging
- Antiplatelet Versus Alteplase in Acute Mild Ischaemic Stroke (ARAMIS): A Multicenter, Open-Label, Blinded-Endpoint, Randomized, Controlled, Noninferiority Trial
- Tirofiban For Disabling Stroke Without Large or Medium Vessel Occlusion
- Extracranial-Intracranial Bypass Surgery Versus Medical Therapy for Symptomatic Carotid and Middle Cerebral Artery Occlusion: Results of the CMOSS Multicenter Randomized Trial
